EH

Encompass Health Corp

EHC
Accountable AI Logo

Encompass Health Corp AI Insights

Informational only. Not investment advice.
As of 2025-12-10

Snapshot

  • ROE of 25% TTM vs industry median 0.6% - 40x advantage from asset-heavy rehab hospital model with 17% operating margins[Return on Equity]
  • Capex of 706M TTM (12% of revenue) consuming 64% of operating cash flow - growth requires heavy reinvestment[Capital Expenditure]
  • Goodwill of 1.3B is 55% of equity; tangible book only 779M vs 10.9B market cap - 14x P/TBV[Goodwill]

Watch Triggers

  • Operating Margin: Falls below 15%Labor costs are 70%+ of rehab hospitals; margin compression signals pricing power erosion
  • Capital Expenditure: Exceeds 15% of revenueHigher capex without revenue acceleration would crush FCF and force debt increase
  • Debt to Equity: Rises above 1.5xCurrent 1.1x manageable; higher leverage with rising rates pressures 126M interest expense

Bull Case

Exceptional profitability moat: 17% operating margin vs 2% industry median with 25% ROE generates 541M net income on asset-intensive model competitors struggle to replicate

Operating MarginROENet Income

Consistent compounder: 25% 3Y EPS CAGR with only 5% revenue growth shows operating leverage; dividend payout ratio 25% leaves room for reinvestment

EPS Growth 3YTotal Revenue 5Y GrowthDividend Payout Ratio

Bear Case

Capital intensity trap: 706M annual capex (12% of revenue) with 1.1x debt/equity and 2.7B total debt limits financial flexibility; FCF only 403M TTM

Capital ExpenditureDebt to EquityFree Cash Flow

Valuation stretched: P/E 20x vs industry 35x looks cheap but P/B 14x and P/TBV 14x reflects intangible-heavy balance sheet risk

P/E RatioP/B RatioTangible Book Value

Bull vs Bear Balance

AI-generated sentiment analysis based on fundamental metrics and market conditions.

BearBull
60%

Leverage EHC's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.

Take Me to The Editor

Forward Thesis

Margin expansion to continue as scale leverage offsets wage inflation

1-3ymed
  • Operating margin 17% TTM with 96% gross margin
  • EPS growth 25% 3Y CAGR outpacing 5% revenue growth
  • G&A at 15% of revenue vs industry median 14%
Net margin 9.3% vs industry median 0.1%ROIC 11% on 4.8B invested capitalEPS 5.31 TTM growing 16% YoY
Valuation Context
Caveats

Public Strategies Rankings

See how Encompass Health Corp ranks across different investment strategies.

Leverage EHC's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.

Data Partners
Morningstar Logo

Fundamental company data provided by Morningstar, updated daily.

Accountable Finance, Inc. Disclaimer
accountable.finance is not operated by a broker or a dealer. Under no circumstances does any information posted on accountable.finance represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. In no event shall accountable.finance be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on accountable.finance, or relating to the use of, or inability to use, accountable.finance or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Stock quotes and fundamental company data provided by Morningstar, updated daily.

Accountable Logo
© 2026 Accountable Finance, Inc. All rights reserved.